Navigation Links
Millennium Announces VELCADE(R) (Bortezomib) for Injection First-Quarter 2008 U.S. Net Sales
Date:4/9/2008

- Strong U.S. sales growth to $83.5 million, up 13 percent over

fourth-quarter 2007 and 42 percent over first-quarter 2007 -

CAMBRIDGE, Mass., April 10 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) today announced first-quarter 2008 U.S. net sales of $83.5 million for its flagship product VELCADE, the global market leader for the treatment of patients with relapsed multiple myeloma. These results represent a 13 percent increase over fourth-quarter 2007 and a 42 percent increase over the first-quarter 2007, significantly exceeding the U.S. Wall Street analyst consensus estimate.

(Logo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

"VELCADE sales continue to strengthen, driven primarily by greater use in patients with relapsed multiple myeloma," said Deborah Dunsire, M.D., President and Chief Executive Officer, Millennium. "We expect to see further sales acceleration should the FDA approve VELCADE for, and after we begin to promote for use in patients with, newly diagnosed multiple myeloma. The FDA decision date is June 20, 2008. We believe an approval could potentially double the number of patients with multiple myeloma eligible to benefit from VELCADE."

About VELCADE

VELCADE is being co-developed by Millennium Pharmaceuticals, Inc. and Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD). Millennium is responsible for commercialization of VELCADE in the U.S. and Janssen-Cilag is responsible for commercialization in Europe and the rest of the world. Janssen Pharmaceutical K.K. is responsible for commercialization in Japan. For a limited period of time, Mil
'/>"/>

SOURCE Millennium Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7

Related biology technology :

1. Millennium Announces $200,000 Purchase Order From Greek Distributor
2. Millennium Biotechnologies, Inc. Signs Marketing and Distribution Agreement with Ferring Pharmaceuticals
3. Millennium Over-Delivers on 2007 Goals and Financial Guidance
4. Millennium Biotechnologies Group Reports 40% Sales Increase for Resurgex Product Line in Greek Market
5. Millennium Announces 2008 Goals for Growth, Building on Record 2007 Results
6. Millennium to Receive $40 Million Milestone Payment for Achievement of Sales Threshold for Velcade(R) (Bortezomib) for Injection
7. Millennium Ships and Records the First $200,000 of Revenue Generated From the Five-Year $20,000,000 Exclusive Purchase Order
8. Millennium Biotechnologies, Inc. Launches SURGEX(TM) the First Scientifically Validated Sports Nutritional Product Created from the Medical Markets
9. Millennium Research Group Offers New Marketrack Service that Tracks European Dental Implant Market
10. Millennium Reports Outstanding Third-Quarter Results Driven by VELCADE(R) (Bortezomib) for Injection Sales
11. Millennium to Webcast Third-Quarter 2007 Financial and Operational Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... A new clinical study presented... shows that three-dimensional (3-D) automated ultr...tware during an in vitro fertilization (IVF) cycle...manual measurement of the follicles. , ...-- The Advanced Fertility Center of Chicago has ju...
(Date:11/30/2009)... , COLUMBUS, Ohio, Nov. 30 The...or one of the nation,s first minority business ear...n Cleveland December 3, is called "Transforming th...iness Early-Stage Capital Summit." It will feature...nority business leaders and local minority entrepr...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCa...tage vaccine company, announced today that the com...Care Conference 2009 on December 2, 2009 at 12:30 ...ovavax will provide an overview of the company,s b...s and upcoming milestones. A link to the live aud...
(Date:11/30/2009)... , ROCKVILLE, Md., Nov. 30 /PRNewswire-FirstCa...day it has completed enrollment in the Phase II cl...2008/2009 recommended strains) VLP vaccine candida...er adults). This randomized, double-blind, active...ility and immunogenicity of two different doses (1...
Breaking Biology Technology:Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 2Computerized IVF Follicle Measurements are Faster and Give High Success Rates, Says Research from Chicago Fertility Doctors Richard Sherbahn and Todd Deutch 3Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 2NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 3NOVAVAX Completes Enrollment in Phase IIa Study of Seasonal Influenza Vaccine in Older Adults 4
... vectors for studying signal transduction pathways...ratagene Cloning Systems, Inc. , Enhancer elemen...r signal,transduction pathways. For simple, rapi...ation of these pathways, Stratagene has designed t...way cis-reporting systems. Each of the cis-reporte...
...cilitate study of DNA mismatch repair , , ... Stratagene has designed RT-PCR primer sets fro...hese genes code for specialized proteins,that pa...n DNA. We have,assembled primer pairs specific f...and mouse (mMSH2, mGTBP, mPMS2 and Rep-3) mismatch...
...,, Reliable restriction enzymes satisfy al...uplent ,Stratagene , Restriction endonucleases...aking the functional purity of critical importance...ee of contaminants that can potentially interfere ... that use digested DNA (i.e.,ligation or sequen...
Other Biology Technology:Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 2Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 3Signal Transduction Reporting Systems Using Cis-Acting Enhancer,Elements 4RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 2RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 3RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 4RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes 5Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal,Performance 2Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal,Performance 3Restriction Endonucleases Undergo Rigorous QC Testing to Ensure Optimal,Performance 4
(Date:12/1/2009)...n July the scientists, one from the United States,...n Brutus, the leader of his wolf pack, on remote E...e. Their goal to finally find out what these "Nor...r in one of the harshest areas of the world., "W...," said David Mech, a renowned U.S. Geological Sur...
(Date:12/1/2009)...n a world first, a Monash University-led internati... to boost the output of the next generation of sol...collaboration with colleagues from the universitie...tandem dye-sensitised solar cells with a three-fol...d with previously reported tandem dye-sensitised s...
(Date:12/1/2009)... Antennas aren,t just for listening to the radio a...s to GPS devices. Research from North Carolina Sta...nna design creating shape-shifting antennas that ...ing from public safety to military deployment. , ...als, but there are limitations to how far they can...
Breaking Biology News(10 mins):North Pole wolf emails locations to researchers 2North Pole wolf emails locations to researchers 3Innovation puts next-generation solar cells on the horizon 2Shape shifters: Researchers create new breed of antennas 2NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 1NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 2NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 3NewCardio Announces Master Services Agreement With Dedicated Phase I 4828 4China Nepstar Chain Drugstore to Announce Second Quarter 2009 Financial Results on August 24 53698 1China Nepstar Chain Drugstore to Announce Second Quarter 2009 Financial Results on August 24 53698 2Brain Fitness Reduces Risk of Onset of Depressive Symptoms 53695 1Brain Fitness Reduces Risk of Onset of Depressive Symptoms 53695 2
...ere are only four specimens of the Yangtze giant s...hree in captivity. In order to save this species f...dlife Conservation Society (WCS) and the Turtle Su... partners from two Chinese zoos and the China Zoo ...roductive, more than 80-year-old, female, living i...
...earchers will present findings on a variety of NAS...8 Joint Assembly of the American Geophysical Union... 30 at the Greater Fort Lauderdale-Broward County ...derdale, Fla. Sessions are open to registered news...ions, in chronological order: , Evaluation of Low...
...HLAND, Wash. -- The pipes that rise from oil field...e fossil fuels and dump carbon dioxide into the ai...ructure of a catalytic material that can turn meth...insight lays the foundation for converting excess ...ls. , "There,s a big interest in doing something ...
Other Biology News:Relocation of endangered Chinese turtle may save species 2NASA presentations at American Geophysical Union Joint Assembly 2NASA presentations at American Geophysical Union Joint Assembly 3NASA presentations at American Geophysical Union Joint Assembly 4NASA presentations at American Geophysical Union Joint Assembly 5Halting methane squanderlust 2Halting methane squanderlust 3
Goat Anti-Human / Mouse / Rat AMPK beta 1 Polyclonal Antibody, Unconjugated from R&D Systems
...c peptide derived from the N-terminal region of hu... for the N-terminus of the ~225 kDa ZO-1 protein. ...s: MDCK-II A431 Caco-2 Rat-1 NRK-52E cells frozen ...er terminal tissues Human pancreas prostate and sm...
Rabbit Anti-Syntrophin alpha 1 Polyclonal Antibody, Unconjugated from Abcam
Anti-Mitotic Kinesin-Like Protein-1 (MKLP-1, KNSL5) Polyclonal Antibody, Unconjugated from CHEMICON
Biology Products: